Cellula OÜ

Active Registry code 14647107 OÜ Tallinn Registered 22 Jan 2019
Compare

Cellula OÜ is a OÜ based in Tallinn, registry code 14647107, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €0 with employees.

Turnover
0 €
State taxes
—
Labour taxes
—
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 0 €
    industry median 0 € · companies in the industry: 1 073

Taxes and turnover

Q2 2024 – Q3 2026
Turnover, € Q3 2026: 0 € · industry median 14 442 € · above 2% of the industry
05 00010 00015 00020 000Q2 2024 Company: 0 € Industry median: 14 999 €Q2·24Q3 2024 Company: 0 € Industry median: 11 985 €Q3·24Q4 2024 Company: 0 € Industry median: 16 752 €Q4·24Q1 2025 Company: 0 € Industry median: 15 203 €Q1·25Q2 2025 Company: 0 € Industry median: 14 420 €Q2·25Q3 2025 Company: 1 329 € Industry median: 13 763 €Q3·25Q4 2025 Company: 1 929 € Industry median: 13 976 €Q4·25Q1 2026 Company: 0 € Industry median: 14 268 €Q1·26Q2 2026 Company: 0 € Industry median: 14 545 €Q2·26Q3 2026 Company: 0 € Industry median: 14 442 €Q3·2605 00010 00015 00020 000Q4 2024 Company: 0 € Industry median: 16 752 €Q1 2025 Company: 0 € Industry median: 15 203 €Q1·25Q2 2025 Company: 0 € Industry median: 14 420 €Q3 2025 Company: 1 329 € Industry median: 13 763 €Q3·25Q4 2025 Company: 1 929 € Industry median: 13 976 €Q1 2026 Company: 0 € Industry median: 14 268 €Q1·26Q2 2026 Company: 0 € Industry median: 14 545 €Q3 2026 Company: 0 € Industry median: 14 442 €Q3·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Labour taxes per employee, € Q2 2025: 4 182 € · +1.1% vs Q1 2025 · industry median 1 781 € · above 75% of the industry
01 0002 0003 0004 0005 000Q2 2024 Company: — Industry median: 2 008 €Q2·24Q3 2024 Company: — Industry median: 1 961 €Q3·24Q4 2024 Company: — Industry median: 1 673 €Q4·24Q1 2025 Company: 4 135 € Industry median: 1 781 €Q1·25Q2 2025 Company: 4 182 € Industry median: 1 781 €Q2·25Q3 2025 Company: — Industry median: 2 044 €Q3·25Q4 2025 Company: — Industry median: 2 069 €Q4·25Q1 2026 Company: — Industry median: 2 039 €Q1·26Q2 2026 Company: — Industry median: 1 893 €Q2·26Q3 2026 Company: — Industry median: 2 218 €Q3·2601 0002 0003 0004 0005 000Q4 2024 Company: — Industry median: 1 673 €Q1 2025 Company: 4 135 € Industry median: 1 781 €Q1·25Q2 2025 Company: 4 182 € Industry median: 1 781 €Q3 2025 Company: — Industry median: 2 044 €Q3·25Q4 2025 Company: — Industry median: 2 069 €Q1 2026 Company: — Industry median: 2 039 €Q1·26Q2 2026 Company: — Industry median: 1 893 €Q3 2026 Company: — Industry median: 2 218 €Q3·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q2 2025: 4 · +0.0% vs Q1 2025
01234Q2 2024 Company: —Q2·24Q3 2024 Company: —Q3·24Q4 2024 Company: 4Q4·24Q1 2025 Company: 4Q1·25Q2 2025 Company: 4Q2·25Q3 2025 Company: —Q3·25Q4 2025 Company: —Q4·25Q1 2026 Company: —Q1·26Q2 2026 Company: —Q2·26Q3 2026 Company: —Q3·2601234Q4 2024 Company: 4Q1 2025 Company: 4Q1·25Q2 2025 Company: 4Q3 2025 Company: —Q3·25Q4 2025 Company: —Q1 2026 Company: —Q1·26Q2 2026 Company: —Q3 2026 Company: —Q3·26
State taxes, € Q2 2026: 0 €
05 00010 00015 00020 000Q2 2024 Company: —Q2·24Q3 2024 Company: 0 €Q3·24Q4 2024 Company: —Q4·24Q1 2025 Company: 15 710 €Q1·25Q2 2025 Company: 15 900 €Q2·25Q3 2025 Company: 15 473 €Q3·25Q4 2025 Company: 5 300 €Q4·25Q1 2026 Company: 0 €Q1·26Q2 2026 Company: 0 €Q2·26Q3 2026 Company: —Q3·2605 00010 00015 00020 000Q4 2024 Company: —Q1 2025 Company: 15 710 €Q1·25Q2 2025 Company: 15 900 €Q3 2025 Company: 15 473 €Q3·25Q4 2025 Company: 5 300 €Q1 2026 Company: 0 €Q1·26Q2 2026 Company: 0 €Q3 2026 Company: —Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — — — —
Q2 2026 — — — —
Q1 2026 — — — —
Q4 2025 1 929 5 300 5 576 —
Q3 2025 1 329 15 473 16 729 —
Q2 2025 — 15 900 16 729 4
Q1 2025 — 15 710 16 539 4
Q4 2024 — — — 4
Q3 2024 — — — —
Q2 2024 — — — —

Financials by year

2019 – 2025
Revenue, € 2025: 0 € · industry median 0 € · above 5% of the industry
0501001502019 Company: 0 € Industry median: 0 €20192020 Company: 0 € Industry median: 150 €20202021 Company: 0 € Industry median: 0 €20212022 Company: 0 € Industry median: 103 €20222023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €20250501001502019 Company: 0 € Industry median: 0 €20192020 Company: 0 € Industry median: 150 €2021 Company: 0 € Industry median: 0 €20212022 Company: 0 € Industry median: 103 €2023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 76 874 € · +1 592.9% vs 2024 · industry median 0 € · above 95% of the industry
020 00040 00060 00080 0002019 Company: 0 € Industry median: 3 €20192020 Company: 0 € Industry median: 28 €20202021 Company: 0 € Industry median: 1 €20212022 Company: 0 € Industry median: 0 €20222023 Company: 0 € Industry median: 0 €20232024 Company: 4 541 € Industry median: 0 €20242025 Company: 76 874 € Industry median: 0 €2025020 00040 00060 00080 0002019 Company: 0 € Industry median: 3 €20192020 Company: 0 € Industry median: 28 €2021 Company: 0 € Industry median: 1 €20212022 Company: 0 € Industry median: 0 €2023 Company: 0 € Industry median: 0 €20232024 Company: 4 541 € Industry median: 0 €2025 Company: 76 874 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 239 935 € · +110.4% vs 2024
0501001502002502019 Company: 2 500 €20192020 Company: 2 500 €20202021 Company: 2 500 €20212022 Company: 2 500 €20222023 Company: 2 500 €20232024 Company: 114 028 €20242025 Company: 239 935 €20250501001502002502019 Company: 2 500 €20192020 Company: 2 500 €2021 Company: 2 500 €20212022 Company: 2 500 €2023 Company: 2 500 €20232024 Company: 114 028 €2025 Company: 239 935 €2025
Equity, € 2025: 83 915 € · +1 091.8% vs 2024
020 00040 00060 00080 000100 0002019 Company: 2 500 €20192020 Company: 2 500 €20202021 Company: 2 500 €20212022 Company: 2 500 €20222023 Company: 2 500 €20232024 Company: 7 041 €20242025 Company: 83 915 €2025020 00040 00060 00080 000100 0002019 Company: 2 500 €20192020 Company: 2 500 €2021 Company: 2 500 €20212022 Company: 2 500 €2023 Company: 2 500 €20232024 Company: 7 041 €2025 Company: 83 915 €2025
Employees 2025: 4 · +0.0% vs 2024 · industry median 1 · above 72% of the industry
012342019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 4 Industry median: 120242025 Company: 4 Industry median: 12025012342019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 4 Industry median: 12025 Company: 4 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 76 874 0 239 935 83 915 4
2024 0 4 541 0 114 028 7 041 4
2023 0 0 0 2 500 2 500 0
2022 0 0 0 2 500 2 500 0
2021 0 0 0 2 500 2 500 0
2020 0 0 0 2 500 2 500 0
2019 0 0 0 2 500 2 500 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
91.6 %
Net profit / equity
Return on assets (ROA)
32.0 %
Net profit / assets
Equity ratio
35.0 %
Equity / assets
Debt ratio
65.0 %
Liabilities / assets
Current ratio
969.50
Current assets / current liabilities
Revenue per employee
0 €
Revenue / average full-time employees
Labour cost per employee per month
0 €
Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 16 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 28 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 26 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 27 Jun 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 28 Jun 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 30 Jun 2021 Company’s own e-Äriregister
2019 22 Jan 2019 – 31 Dec 2019 2 Oct 2020 Company’s own e-Äriregister

Board

  • Jüri Liiv
    Board member · since 25 Mar 2024
  • Marek Nugis
    Board member · since 27 May 2026
  • Nasdaq CSD SE
    Keeper of the share register · since 3 Apr 2024

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Owner in

Beneficial owners

  • Jüri Liiv
    Direct ownership · since 15 Apr 2024

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72101Research and experimental development on natural sciences and engineering Main
Rulings
Number, date Title Deadline State Document
Ä 50111146 / 9
26 Jun 2026
Amendment entry In force
26 Jun 2026
PDF
Ä 50111146 / 8
27 May 2026
Amendment entry In force
27 May 2026
PDF
Ä 50111146 / 7
13 Jan 2026
Amendment entry In force
13 Jan 2026
PDF
Ä 50111146 / 6
9 Jan 2026
Amendment under Code of Civil Procedure § 595¹ (1) In force
9 Jan 2026
PDF
Ä 50111146 / 5
16 Oct 2024
Amendment entry In force
16 Oct 2024
PDF
Ä 50111146 / 4
3 Apr 2024
Amendment entry In force
3 Apr 2024
PDF
Ä 50111146 / 3
25 Mar 2024
Amendment entry In force
25 Mar 2024
PDF
Ä 50111146 / 2
3 Sep 2023
Amendment entry In force
3 Sep 2023
PDF
Ä 50111146
22 Jan 2019
First entry In force
22 Jan 2019
PDF
Ä 50111146 / M1
18 Jan 2019
Ruling to eliminate deficiencies 1 Feb 2019 Deficiencies eliminated
22 Jan 2019
PDF

Sources: e-Äriregister and EMTA. Data updated 29 Oct 2026. Open at the source ↗ · Report an error in the data